Movatterモバイル変換


[0]ホーム

URL:


US20080139902A1 - Method and device for continuous monitoring of the concentration of an analyte - Google Patents

Method and device for continuous monitoring of the concentration of an analyte
Download PDF

Info

Publication number
US20080139902A1
US20080139902A1US11/870,606US87060607AUS2008139902A1US 20080139902 A1US20080139902 A1US 20080139902A1US 87060607 AUS87060607 AUS 87060607AUS 2008139902 A1US2008139902 A1US 2008139902A1
Authority
US
United States
Prior art keywords
measurement
signal
time
filter algorithm
actual
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US11/870,606
Other versions
US7389133B1 (en
Inventor
Reinhard Kotulla
Arnulf Staib
Ralph Gillen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diabetes Care Inc
Original Assignee
Roche Diagnostics Operations Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Operations IncfiledCriticalRoche Diagnostics Operations Inc
Priority to US11/870,606priorityCriticalpatent/US7389133B1/en
Assigned to ROCHE DIAGNOSTICS OPERATIONS, INC.reassignmentROCHE DIAGNOSTICS OPERATIONS, INC.ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).Assignors: ROCHE DIAGNOSTICS GMBH
Assigned to ROCHE DIAGNOSTICS GMBHreassignmentROCHE DIAGNOSTICS GMBHASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).Assignors: GILLEN, RALPH, STAIB, ARNULF, KOTULLA, REINHARD
Publication of US20080139902A1publicationCriticalpatent/US20080139902A1/en
Application grantedgrantedCritical
Publication of US7389133B1publicationCriticalpatent/US7389133B1/en
Assigned to ROCHE DIABETES CARE, INC.reassignmentROCHE DIABETES CARE, INC.ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).Assignors: ROCHE DIAGNOSTICS OPERATIONS, INC.
Anticipated expirationlegal-statusCritical
Expired - Lifetimelegal-statusCriticalCurrent

Links

Images

Classifications

Definitions

Landscapes

Abstract

The disclosure generally relates to continuous monitoring of an analyte by determining its change over time in the living body of a human or animal. A measurement, variable value correlating with the desired concentration of the analyte are measured as the measurement signal (zt) and the change over time of the concentration is determined from the measurement signal as the useful signal (yt) using a calibration. A filter algorithm is used to reduce errors of thee useful signal, which result from noise contained in the measurement signal. The filter algorithm includes an operation in which the influence of an actual measurement value on the useful signal is weighted using a weighting factor (V).

Description

Claims (10)

1. A method for continuous monitoring concentration of an analyte by determining the analyte's change over time in the living body of a human or animal, the method comprising:
measuring at sequential points in time measurement values of a measurement variable correlating with a desired concentration of the analyte;
measuring the measurement variable as a measurement signal (zt);
determining the change over time of the concentration of the analyte from the measurement signal as a useful signal (yt) by means of a calibration;
providing a filter algorithm in the time domain for determination of the useful signal (yt) from the measurement signal (zt), wherein the filter algorithm reduces errors of the useful signal resulting from noise contained in the measurement signal, wherein the filter algorithm includes an operation in which the influence of an actual measurement value on the useful signal is weighted by means of a weighting factor (V);
determining a time dependent signal variation parameter (σt) related to an actual point of time on the basis of signal variations detected in close chronological relation to the measurement of the actual measurement value;
wherein the time dependent signal variation parameter being a measure for signal variations for a period of time preceding an actual measurement value and being determined oil the basis of measurement values including values which were measured less than 30 minutes before the measurement of the actual value; and
adapting dynamically the weighting factor as a function of the signal variation parameter determined for the point in time of the actual measurement, the weighting factor being changed in such a direction that the influence of the actual measurement value is reduced with increasing standard deviation of the measurement signal.
10. A device for continuous monitoring of a concentration of an analyte by determining the analyte' s change over time in the living body of a human or animal, the device comprising:
a measurement unit, by which measurement values of a measurement variable correlating with the desired concentration are measured as the measurement signal (zt) at sequential points in time;
an analysis unit, by which the change over time of the concentration is determined by means of a calibration as a useful signal (yt) from the measurement signal, and
a filter algorithm in the time domain for determination of the useful signal (yt) from the measurement signal (zt) to reduce errors of the useful signal, which result from noise contained in the measurement signal;
wherein the filter algorithm includes operations, in which the influence of an actual measurement value on the useful signal is weighted using a weighting factor (V), such that a time dependent signal variation parameter (σt) is determined on the basis of signal variations detected in close chronological relationship with the measurement of the actual measurement value, wherein the time dependent signal variation parameter being a measure for signal variations for a period of time preceding an actual measurement value and being determined on the basis of measurement values including values which were measured less than 30 minutes before the measurement of the actual value; and
the weighting factor is dynamically adapted as a function of the signal variation parameter determined for the point in time of the actual measurement, the weighting factor being changed in such a direction that the influence of the actual measurement value is reduced with increasing standard deviation of the measurement signal.
US11/870,6062003-09-232007-10-11Method and device for continuous monitoring of the concentration of an analyteExpired - LifetimeUS7389133B1 (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
US11/870,606US7389133B1 (en)2003-09-232007-10-11Method and device for continuous monitoring of the concentration of an analyte

Applications Claiming Priority (5)

Application NumberPriority DateFiling DateTitle
DEDE10343863.72003-09-23
DE10343863ADE10343863A1 (en)2003-09-232003-09-23 Method and device for continuously monitoring the concentration of an analyte
US10/945,798US20050272985A1 (en)2003-09-232004-09-21Method and device for continuous monitoring of the concentration of an analyte
US11/266,637US20060052679A1 (en)2003-09-232005-11-03Method and device for continuous monitoring of the concentration of an analyte
US11/870,606US7389133B1 (en)2003-09-232007-10-11Method and device for continuous monitoring of the concentration of an analyte

Related Parent Applications (1)

Application NumberTitlePriority DateFiling Date
US11/266,637ContinuationUS20060052679A1 (en)2003-09-232005-11-03Method and device for continuous monitoring of the concentration of an analyte

Publications (2)

Publication NumberPublication Date
US20080139902A1true US20080139902A1 (en)2008-06-12
US7389133B1 US7389133B1 (en)2008-06-17

Family

ID=34177889

Family Applications (3)

Application NumberTitlePriority DateFiling Date
US10/945,798AbandonedUS20050272985A1 (en)2003-09-232004-09-21Method and device for continuous monitoring of the concentration of an analyte
US11/266,637AbandonedUS20060052679A1 (en)2003-09-232005-11-03Method and device for continuous monitoring of the concentration of an analyte
US11/870,606Expired - LifetimeUS7389133B1 (en)2003-09-232007-10-11Method and device for continuous monitoring of the concentration of an analyte

Family Applications Before (2)

Application NumberTitlePriority DateFiling Date
US10/945,798AbandonedUS20050272985A1 (en)2003-09-232004-09-21Method and device for continuous monitoring of the concentration of an analyte
US11/266,637AbandonedUS20060052679A1 (en)2003-09-232005-11-03Method and device for continuous monitoring of the concentration of an analyte

Country Status (7)

CountryLink
US (3)US20050272985A1 (en)
EP (1)EP1518495B1 (en)
JP (1)JP4040614B2 (en)
AT (1)ATE462350T1 (en)
CA (1)CA2481627C (en)
DE (2)DE10343863A1 (en)
ES (1)ES2340383T3 (en)

Cited By (38)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US20090271008A1 (en)*2008-04-242009-10-29Searete Llc, A Limited Liability Corporation Of The State Of DelawareCombination treatment modification methods and systems
US20090271121A1 (en)*2008-04-242009-10-29Searete Llc, A Limited Liability Corporation Of The State Of DelawareMethods and systems for detecting a bioactive agent effect
US20090271009A1 (en)*2008-04-242009-10-29Searete Llc, A Limited Liability Corporation Of The State Of DelawareCombination treatment modification methods and systems
US20090270786A1 (en)*2008-04-242009-10-29Searete Llc, A Limited Liability Corporation Of The State Of DelawareMethods and systems for presenting a combination treatment
US20090271219A1 (en)*2008-04-242009-10-29Searete Llc, A Limited Liability Corporation Of The Stste Of DelawareMethods and systems for presenting a combination treatment
US20090271122A1 (en)*2008-04-242009-10-29Searete Llc, A Limited Liability Corporation Of The State Of DelawareMethods and systems for monitoring and modifying a combination treatment
US20090270694A1 (en)*2008-04-242009-10-29Searete Llc, A Limited Liability Corporation Of The State Of DelawareMethods and systems for monitoring and modifying a combination treatment
US20090271120A1 (en)*2008-04-242009-10-29Searete Llc, A Limited Liability Corporation Of The State Of DelawareMethods and systems for monitoring bioactive agent use
US20090270688A1 (en)*2008-04-242009-10-29Searete Llc, A Limited Liability Corporation Of The State Of DelawareMethods and systems for presenting a combination treatment
US20090271375A1 (en)*2008-04-242009-10-29Searete Llc, A Limited Liability Corporation Of The State Of DelawareCombination treatment selection methods and systems
US20090271215A1 (en)*2008-04-242009-10-29Searete Llc, A Limited Liability Corporation Of The State Of DelawareMethods and systems for detecting a bioactive agent effect
US20090271347A1 (en)*2008-04-242009-10-29Searete Llc, A Limited Liability Corporation Of The State Of DelawareMethods and systems for monitoring bioactive agent use
US20090269329A1 (en)*2008-04-242009-10-29Searete Llc, A Limited Liability Corporation Of The State Of DelawareCombination Therapeutic products and systems
US20090270687A1 (en)*2008-04-242009-10-29Searete Llc, A Limited Liability Corporation Of The State Of DelawareMethods and systems for modifying bioactive agent use
US20090292676A1 (en)*2008-04-242009-11-26Searete Llc, A Limited Liability Corporation Of The State Of DelawareCombination treatment selection methods and systems
US20090312668A1 (en)*2008-04-242009-12-17Searete Llc, A Limited Liability Corporation Of The State Of DelawareComputational system and method for memory modification
US20090319301A1 (en)*2008-04-242009-12-24Searete Llc, A Limited Liability Corporation Of The State Of DelawarMethods and systems for presenting a combination treatment
US20100004762A1 (en)*2008-04-242010-01-07Searete Llc, A Limited Liability Corporation Of The State Of DelawareComputational system and method for memory modification
US20100015583A1 (en)*2008-04-242010-01-21Searete Llc, A Limited Liability Corporation Of The State Of DelawareComputational System and method for memory modification
US20100017001A1 (en)*2008-04-242010-01-21Searete Llc, A Limited Liability Corporation Of The State Of DelawareComputational system and method for memory modification
US20100022820A1 (en)*2008-04-242010-01-28Searete Llc, A Limited Liability Corporation Of The State Of DelawareComputational system and method for memory modification
US20100030089A1 (en)*2008-04-242010-02-04Searete Llc, A Limited Liability Corporation Of The State Of DelawareMethods and systems for monitoring and modifying a combination treatment
US20100042578A1 (en)*2008-04-242010-02-18Searete Llc, A Limited Liability Corporation Of The State Of DelawareComputational system and method for memory modification
US20100041964A1 (en)*2008-04-242010-02-18Searete Llc, A Limited Liability Corporation Of The State Of DelawareMethods and systems for monitoring and modifying a combination treatment
US20100041958A1 (en)*2008-04-242010-02-18Searete LlcComputational system and method for memory modification
US20100076249A1 (en)*2008-04-242010-03-25Searete Llc, A Limited Liability Corporation Of The State Of DelawareComputational system and method for memory modification
US20100081861A1 (en)*2008-04-242010-04-01Searete LlcComputational System and Method for Memory Modification
US20100081860A1 (en)*2008-04-242010-04-01Searete Llc, A Limited Liability Corporation Of The State Of DelawareComputational System and Method for Memory Modification
US20100125561A1 (en)*2008-04-242010-05-20Searete Llc, A Limited Liability Corporation Of The State Of DelawareComputational system and method for memory modification
US7801686B2 (en)2008-04-242010-09-21The Invention Science Fund I, LlcCombination treatment alteration methods and systems
US7974787B2 (en)2008-04-242011-07-05The Invention Science Fund I, LlcCombination treatment alteration methods and systems
CN104138250A (en)*2008-12-292014-11-12美敦力迷你迈德公司System and/or method for glucose sensor calibration
US9064036B2 (en)2008-04-242015-06-23The Invention Science Fund I, LlcMethods and systems for monitoring bioactive agent use
US9282927B2 (en)2008-04-242016-03-15Invention Science Fund I, LlcMethods and systems for modifying bioactive agent use
US9449150B2 (en)2008-04-242016-09-20The Invention Science Fund I, LlcCombination treatment selection methods and systems
US9560967B2 (en)2008-04-242017-02-07The Invention Science Fund I LlcSystems and apparatus for measuring a bioactive agent effect
US9662391B2 (en)2008-04-242017-05-30The Invention Science Fund I LlcSide effect ameliorating combination therapeutic products and systems
CN114943249A (en)*2022-05-132022-08-26福州九候生医科技有限公司 Blood component detection method and related equipment

Families Citing this family (123)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US8480580B2 (en)1998-04-302013-07-09Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8346337B2 (en)1998-04-302013-01-01Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8465425B2 (en)1998-04-302013-06-18Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8974386B2 (en)1998-04-302015-03-10Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8688188B2 (en)1998-04-302014-04-01Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US9066695B2 (en)1998-04-302015-06-30Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US6175752B1 (en)1998-04-302001-01-16Therasense, Inc.Analyte monitoring device and methods of use
US6949816B2 (en)2003-04-212005-09-27Motorola, Inc.Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same
US6560471B1 (en)2001-01-022003-05-06Therasense, Inc.Analyte monitoring device and methods of use
EP1397068A2 (en)2001-04-022004-03-17Therasense, Inc.Blood glucose tracking apparatus and methods
US7993108B2 (en)2002-10-092011-08-09Abbott Diabetes Care Inc.Variable volume, shape memory actuated insulin dispensing pump
DE60336834D1 (en)2002-10-092011-06-01Abbott Diabetes Care Inc FUEL FEEDING DEVICE, SYSTEM AND METHOD
US7727181B2 (en)2002-10-092010-06-01Abbott Diabetes Care Inc.Fluid delivery device with autocalibration
US7811231B2 (en)2002-12-312010-10-12Abbott Diabetes Care Inc.Continuous glucose monitoring system and methods of use
US7679407B2 (en)2003-04-282010-03-16Abbott Diabetes Care Inc.Method and apparatus for providing peak detection circuitry for data communication systems
US8066639B2 (en)2003-06-102011-11-29Abbott Diabetes Care Inc.Glucose measuring device for use in personal area network
WO2005089103A2 (en)2004-02-172005-09-29Therasense, Inc.Method and system for providing data communication in continuous glucose monitoring and management system
DE102004020160A1 (en)2004-04-242005-11-10Roche Diagnostics Gmbh Method and device for monitoring a concentration of an analyte in the living body of a human or animal
US9636450B2 (en)2007-02-192017-05-02Udo HossPump system modular components for delivering medication and analyte sensing at seperate insertion sites
US7545272B2 (en)2005-02-082009-06-09Therasense, Inc.RF tag on test strips, test strip vials and boxes
JP2008535548A (en)2005-03-212008-09-04アボット ダイアビーティーズ ケア インコーポレイテッド Method and system for providing an integrated pharmaceutical infusion / specimen monitoring system
US8112240B2 (en)2005-04-292012-02-07Abbott Diabetes Care Inc.Method and apparatus for providing leak detection in data monitoring and management systems
US7768408B2 (en)2005-05-172010-08-03Abbott Diabetes Care Inc.Method and system for providing data management in data monitoring system
US7620437B2 (en)2005-06-032009-11-17Abbott Diabetes Care Inc.Method and apparatus for providing rechargeable power in data monitoring and management systems
US8880138B2 (en)2005-09-302014-11-04Abbott Diabetes Care Inc.Device for channeling fluid and methods of use
US7756561B2 (en)2005-09-302010-07-13Abbott Diabetes Care Inc.Method and apparatus for providing rechargeable power in data monitoring and management systems
US7583190B2 (en)2005-10-312009-09-01Abbott Diabetes Care Inc.Method and apparatus for providing data communication in data monitoring and management systems
US7766829B2 (en)2005-11-042010-08-03Abbott Diabetes Care Inc.Method and system for providing basal profile modification in analyte monitoring and management systems
US8344966B2 (en)2006-01-312013-01-01Abbott Diabetes Care Inc.Method and system for providing a fault tolerant display unit in an electronic device
US7826879B2 (en)2006-02-282010-11-02Abbott Diabetes Care Inc.Analyte sensors and methods of use
US8140312B2 (en)2007-05-142012-03-20Abbott Diabetes Care Inc.Method and system for determining analyte levels
US8478557B2 (en)2009-07-312013-07-02Abbott Diabetes Care Inc.Method and apparatus for providing analyte monitoring system calibration accuracy
US7618369B2 (en)2006-10-022009-11-17Abbott Diabetes Care Inc.Method and system for dynamically updating calibration parameters for an analyte sensor
US8226891B2 (en)2006-03-312012-07-24Abbott Diabetes Care Inc.Analyte monitoring devices and methods therefor
US7653425B2 (en)2006-08-092010-01-26Abbott Diabetes Care Inc.Method and system for providing calibration of an analyte sensor in an analyte monitoring system
US9392969B2 (en)2008-08-312016-07-19Abbott Diabetes Care Inc.Closed loop control and signal attenuation detection
US8374668B1 (en)2007-10-232013-02-12Abbott Diabetes Care Inc.Analyte sensor with lag compensation
US7801582B2 (en)2006-03-312010-09-21Abbott Diabetes Care Inc.Analyte monitoring and management system and methods therefor
US8473022B2 (en)2008-01-312013-06-25Abbott Diabetes Care Inc.Analyte sensor with time lag compensation
US7620438B2 (en)2006-03-312009-11-17Abbott Diabetes Care Inc.Method and system for powering an electronic device
WO2007143225A2 (en)2006-06-072007-12-13Abbott Diabetes Care, Inc.Analyte monitoring system and method
EP2083673B1 (en)*2006-09-292012-07-04Medingo Ltd.Fluid delivery system with electrochemical sensing of analyte concentration levels
US8579853B2 (en)2006-10-312013-11-12Abbott Diabetes Care Inc.Infusion devices and methods
US8930203B2 (en)2007-02-182015-01-06Abbott Diabetes Care Inc.Multi-function analyte test device and methods therefor
US8732188B2 (en)2007-02-182014-05-20Abbott Diabetes Care Inc.Method and system for providing contextual based medication dosage determination
US8123686B2 (en)2007-03-012012-02-28Abbott Diabetes Care Inc.Method and apparatus for providing rolling data in communication systems
CA2683953C (en)2007-04-142016-08-02Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in medical communication system
US10111608B2 (en)2007-04-142018-10-30Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in medical communication system
WO2008130897A2 (en)2007-04-142008-10-30Abbott Diabetes Care, Inc.Method and apparatus for providing data processing and control in medical communication system
WO2008130898A1 (en)2007-04-142008-10-30Abbott Diabetes Care, Inc.Method and apparatus for providing data processing and control in medical communication system
US7928850B2 (en)2007-05-082011-04-19Abbott Diabetes Care Inc.Analyte monitoring system and methods
US8461985B2 (en)2007-05-082013-06-11Abbott Diabetes Care Inc.Analyte monitoring system and methods
US8665091B2 (en)2007-05-082014-03-04Abbott Diabetes Care Inc.Method and device for determining elapsed sensor life
US8456301B2 (en)2007-05-082013-06-04Abbott Diabetes Care Inc.Analyte monitoring system and methods
US8600681B2 (en)2007-05-142013-12-03Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication system
US8239166B2 (en)2007-05-142012-08-07Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication system
US8260558B2 (en)2007-05-142012-09-04Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication system
US10002233B2 (en)2007-05-142018-06-19Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication system
US9125548B2 (en)2007-05-142015-09-08Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication system
US8103471B2 (en)2007-05-142012-01-24Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication system
US8560038B2 (en)2007-05-142013-10-15Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication system
US8444560B2 (en)*2007-05-142013-05-21Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication system
US8834366B2 (en)2007-07-312014-09-16Abbott Diabetes Care Inc.Method and apparatus for providing analyte sensor calibration
US20090143725A1 (en)*2007-08-312009-06-04Abbott Diabetes Care, Inc.Method of Optimizing Efficacy of Therapeutic Agent
DE102007046864A1 (en)*2007-09-282009-04-09Endress + Hauser Conducta Gesellschaft für Mess- und Regeltechnik mbH + Co. KGMeasured value plausibility and quality evaluating method for e.g. control circuit, involves forming and evaluating derivative of measured value according to time, where measured value is compared with predefined warning limit value
US8409093B2 (en)2007-10-232013-04-02Abbott Diabetes Care Inc.Assessing measures of glycemic variability
US8377031B2 (en)2007-10-232013-02-19Abbott Diabetes Care Inc.Closed loop control system with safety parameters and methods
US20090164239A1 (en)2007-12-192009-06-25Abbott Diabetes Care, Inc.Dynamic Display Of Glucose Information
US8876755B2 (en)2008-07-142014-11-04Abbott Diabetes Care Inc.Closed loop control system interface and methods
US8734422B2 (en)2008-08-312014-05-27Abbott Diabetes Care Inc.Closed loop control with improved alarm functions
US9943644B2 (en)2008-08-312018-04-17Abbott Diabetes Care Inc.Closed loop control with reference measurement and methods thereof
US8622988B2 (en)2008-08-312014-01-07Abbott Diabetes Care Inc.Variable rate closed loop control and methods
US20100057040A1 (en)2008-08-312010-03-04Abbott Diabetes Care, Inc.Robust Closed Loop Control And Methods
US8986208B2 (en)2008-09-302015-03-24Abbott Diabetes Care Inc.Analyte sensor sensitivity attenuation mitigation
CA2747309C (en)2008-12-232023-09-26F. Hoffmann-La Roche AgStructured testing method for diagnostic or therapy support of a patient with a chronic disease and devices thereof
US20120011125A1 (en)2008-12-232012-01-12Roche Diagnostics Operations, Inc.Management method and system for implementation, execution, data collection, and data analysis of a structured collection procedure which runs on a collection device
US10437962B2 (en)2008-12-232019-10-08Roche Diabetes Care IncStatus reporting of a structured collection procedure
US9918635B2 (en)2008-12-232018-03-20Roche Diabetes Care, Inc.Systems and methods for optimizing insulin dosage
US8849458B2 (en)2008-12-232014-09-30Roche Diagnostics Operations, Inc.Collection device with selective display of test results, method and computer program product thereof
US9117015B2 (en)2008-12-232015-08-25Roche Diagnostics Operations, Inc.Management method and system for implementation, execution, data collection, and data analysis of a structured collection procedure which runs on a collection device
US10456036B2 (en)2008-12-232019-10-29Roche Diabetes Care, Inc.Structured tailoring
US10471207B2 (en)2008-12-292019-11-12Medtronic Minimed, Inc.System and/or method for glucose sensor calibration
US8103456B2 (en)2009-01-292012-01-24Abbott Diabetes Care Inc.Method and device for early signal attenuation detection using blood glucose measurements
US8560082B2 (en)2009-01-302013-10-15Abbott Diabetes Care Inc.Computerized determination of insulin pump therapy parameters using real time and retrospective data processing
WO2010129375A1 (en)2009-04-282010-11-11Abbott Diabetes Care Inc.Closed loop blood glucose control algorithm analysis
WO2010127050A1 (en)2009-04-282010-11-04Abbott Diabetes Care Inc.Error detection in critical repeating data in a wireless sensor system
WO2010138856A1 (en)2009-05-292010-12-02Abbott Diabetes Care Inc.Medical device antenna systems having external antenna configurations
US8798934B2 (en)2009-07-232014-08-05Abbott Diabetes Care Inc.Real time management of data relating to physiological control of glucose levels
DK3689237T3 (en)2009-07-232021-08-16Abbott Diabetes Care Inc Method of preparation and system for continuous analyte measurement
EP2290371A1 (en)2009-08-272011-03-02F. Hoffmann-La Roche AGCalibration method for prospective calibration of a measuring device
US8993331B2 (en)2009-08-312015-03-31Abbott Diabetes Care Inc.Analyte monitoring system and methods for managing power and noise
US9314195B2 (en)2009-08-312016-04-19Abbott Diabetes Care Inc.Analyte signal processing device and methods
US9320461B2 (en)2009-09-292016-04-26Abbott Diabetes Care Inc.Method and apparatus for providing notification function in analyte monitoring systems
EP2305105B1 (en)*2009-10-052012-05-16Roche Diagnostics GmbHMethods for the detection of a malfunction in a sensor for in-vivo analyte measurement
US20110092788A1 (en)*2009-10-152011-04-21Roche Diagnostics Operations, Inc.Systems And Methods For Providing Guidance In Administration Of A Medicine
US20110118578A1 (en)*2009-11-172011-05-19Roche Diagnostics Operations, Inc.Hypoglycemic treatment methods and systems
US20120088989A1 (en)2009-12-212012-04-12Roche Diagnostic Operations, Inc.Management Method And System For Implementation, Execution, Data Collection, and Data Analysis of A Structured Collection Procedure Which Runs On A Collection Device
US8843321B2 (en)*2010-01-262014-09-23Roche Diagnostics Operations, Inc.Methods and systems for processing glucose data measured from a person having diabetes
US8532933B2 (en)2010-06-182013-09-10Roche Diagnostics Operations, Inc.Insulin optimization systems and testing methods with adjusted exit criterion accounting for system noise associated with biomarkers
US11213226B2 (en)2010-10-072022-01-04Abbott Diabetes Care Inc.Analyte monitoring devices and methods
US9262586B2 (en)2010-12-202016-02-16Roche Diabetes Care, Inc.Representation of large, variable size data sets on small displays
US20120173151A1 (en)2010-12-292012-07-05Roche Diagnostics Operations, Inc.Methods of assessing diabetes treatment protocols based on protocol complexity levels and patient proficiency levels
US8766803B2 (en)2011-05-132014-07-01Roche Diagnostics Operations, Inc.Dynamic data collection
US8755938B2 (en)2011-05-132014-06-17Roche Diagnostics Operations, Inc.Systems and methods for handling unacceptable values in structured collection protocols
US9974472B2 (en)2011-06-162018-05-22Abbott Diabetes Care Inc.Temperature-compensated analyte monitoring devices, systems, and methods thereof
EP2760336B1 (en)*2011-09-282018-09-19Abbott Diabetes Care Inc.Methods, devices and systems for analyte monitoring management
WO2013070794A2 (en)2011-11-072013-05-16Abbott Diabetes Care Inc.Analyte monitoring device and methods
US9317656B2 (en)2011-11-232016-04-19Abbott Diabetes Care Inc.Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereof
US8710993B2 (en)2011-11-232014-04-29Abbott Diabetes Care Inc.Mitigating single point failure of devices in an analyte monitoring system and methods thereof
US10132793B2 (en)2012-08-302018-11-20Abbott Diabetes Care Inc.Dropout detection in continuous analyte monitoring data during data excursions
US20140068487A1 (en)2012-09-052014-03-06Roche Diagnostics Operations, Inc.Computer Implemented Methods For Visualizing Correlations Between Blood Glucose Data And Events And Apparatuses Thereof
US9968306B2 (en)2012-09-172018-05-15Abbott Diabetes Care Inc.Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
US9119529B2 (en)2012-10-302015-09-01Dexcom, Inc.Systems and methods for dynamically and intelligently monitoring a host's glycemic condition after an alert is triggered
WO2014068743A1 (en)2012-11-012014-05-08テルモ株式会社Sensing device and sensing method
US10788416B2 (en)*2013-10-032020-09-29Rosemount Inc.Multiple wavelength light source for colorimetric measurement
DE202016009220U1 (en)2015-07-102024-07-09Abbott Diabetes Care, Inc. Device and system for dynamic glucose profile response to physiological parameters
US10765373B2 (en)2016-04-292020-09-08Senseonics, IncorporatedReal-time denoising and prediction for a continuous glucose monitoring system
CN109640796B (en)*2016-06-292022-12-06豪夫迈·罗氏有限公司 Method for providing a signal quality measure associated with an analyte value measured in a continuous monitoring system
WO2018175489A1 (en)2017-03-212018-09-27Abbott Diabetes Care Inc.Methods, devices and system for providing diabetic condition diagnosis and therapy
AU2018261124B2 (en)2017-05-052021-01-28Ypsomed AgClosed loop control of physiological glucose
EP3687400B1 (en)2017-09-262023-10-04Senseonics, IncorporatedMethods and systems for updating lag parameters
US11901060B2 (en)2017-12-212024-02-13Ypsomed AgClosed loop control of physiological glucose
CA3103479A1 (en)2018-06-222019-12-26Eli Lilly And CompanyInsulin and pramlintide delivery systems, methods, and devices

Citations (9)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US5507288A (en)*1994-05-051996-04-16Boehringer Mannheim GmbhAnalytical system for monitoring a substance to be analyzed in patient-blood
US5921937A (en)*1997-03-251999-07-13Davis; Dennis W.Method and system for extraction and detection of physiological features
US6272480B1 (en)*1997-10-172001-08-07Siemens AktiengesellschaftMethod and arrangement for the neural modelling of a dynamic system with non-linear stochastic behavior
US6317662B1 (en)*2000-07-242001-11-13Hughes Electronics CorporationStable and verifiable state estimation methods and systems with spacecraft applications
US6519705B1 (en)*1999-12-152003-02-11At&T Corp.Method and system for power control in wireless networks using interference prediction with an error margin
US6572545B2 (en)*2000-09-222003-06-03Knobbe, Lim & BuckinghamMethod and apparatus for real-time control of physiological parameters
US6584335B1 (en)*1997-08-092003-06-24Roche Diagnostics GmbhAnalytical device for in vivo analysis in the body of a patient
US20030130616A1 (en)*1999-06-032003-07-10Medtronic Minimed, Inc.Closed loop system for controlling insulin infusion
US6740518B1 (en)*1998-09-172004-05-25Clinical Micro Sensors, Inc.Signal detection techniques for the detection of analytes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
JP2001517991A (en)*1997-03-212001-10-09ネルコー・ピューリタン・ベネット・インコーポレイテッド Data signal adaptive averaging method and apparatus
US6340346B1 (en)1999-11-262002-01-22T.A.O. Medical Technologies Ltd.Method and system for system identification of physiological systems

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US5507288A (en)*1994-05-051996-04-16Boehringer Mannheim GmbhAnalytical system for monitoring a substance to be analyzed in patient-blood
US5507288B1 (en)*1994-05-051997-07-08Boehringer Mannheim GmbhAnalytical system for monitoring a substance to be analyzed in patient-blood
US5921937A (en)*1997-03-251999-07-13Davis; Dennis W.Method and system for extraction and detection of physiological features
US6584335B1 (en)*1997-08-092003-06-24Roche Diagnostics GmbhAnalytical device for in vivo analysis in the body of a patient
US6272480B1 (en)*1997-10-172001-08-07Siemens AktiengesellschaftMethod and arrangement for the neural modelling of a dynamic system with non-linear stochastic behavior
US6740518B1 (en)*1998-09-172004-05-25Clinical Micro Sensors, Inc.Signal detection techniques for the detection of analytes
US20030130616A1 (en)*1999-06-032003-07-10Medtronic Minimed, Inc.Closed loop system for controlling insulin infusion
US6519705B1 (en)*1999-12-152003-02-11At&T Corp.Method and system for power control in wireless networks using interference prediction with an error margin
US6317662B1 (en)*2000-07-242001-11-13Hughes Electronics CorporationStable and verifiable state estimation methods and systems with spacecraft applications
US6572545B2 (en)*2000-09-222003-06-03Knobbe, Lim & BuckinghamMethod and apparatus for real-time control of physiological parameters
US6575905B2 (en)*2000-09-222003-06-10Knobbe, Lim & BuckinghamMethod and apparatus for real-time estimation of physiological parameters

Cited By (50)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US20100041958A1 (en)*2008-04-242010-02-18Searete LlcComputational system and method for memory modification
US9449150B2 (en)2008-04-242016-09-20The Invention Science Fund I, LlcCombination treatment selection methods and systems
US20090271009A1 (en)*2008-04-242009-10-29Searete Llc, A Limited Liability Corporation Of The State Of DelawareCombination treatment modification methods and systems
US20090270786A1 (en)*2008-04-242009-10-29Searete Llc, A Limited Liability Corporation Of The State Of DelawareMethods and systems for presenting a combination treatment
US20090271219A1 (en)*2008-04-242009-10-29Searete Llc, A Limited Liability Corporation Of The Stste Of DelawareMethods and systems for presenting a combination treatment
US20090271122A1 (en)*2008-04-242009-10-29Searete Llc, A Limited Liability Corporation Of The State Of DelawareMethods and systems for monitoring and modifying a combination treatment
US20090270694A1 (en)*2008-04-242009-10-29Searete Llc, A Limited Liability Corporation Of The State Of DelawareMethods and systems for monitoring and modifying a combination treatment
US20090271120A1 (en)*2008-04-242009-10-29Searete Llc, A Limited Liability Corporation Of The State Of DelawareMethods and systems for monitoring bioactive agent use
US20090270688A1 (en)*2008-04-242009-10-29Searete Llc, A Limited Liability Corporation Of The State Of DelawareMethods and systems for presenting a combination treatment
US20090271375A1 (en)*2008-04-242009-10-29Searete Llc, A Limited Liability Corporation Of The State Of DelawareCombination treatment selection methods and systems
US20090271215A1 (en)*2008-04-242009-10-29Searete Llc, A Limited Liability Corporation Of The State Of DelawareMethods and systems for detecting a bioactive agent effect
US20090271347A1 (en)*2008-04-242009-10-29Searete Llc, A Limited Liability Corporation Of The State Of DelawareMethods and systems for monitoring bioactive agent use
US20090269329A1 (en)*2008-04-242009-10-29Searete Llc, A Limited Liability Corporation Of The State Of DelawareCombination Therapeutic products and systems
US20090270687A1 (en)*2008-04-242009-10-29Searete Llc, A Limited Liability Corporation Of The State Of DelawareMethods and systems for modifying bioactive agent use
US20090292676A1 (en)*2008-04-242009-11-26Searete Llc, A Limited Liability Corporation Of The State Of DelawareCombination treatment selection methods and systems
US20090312668A1 (en)*2008-04-242009-12-17Searete Llc, A Limited Liability Corporation Of The State Of DelawareComputational system and method for memory modification
US20090319301A1 (en)*2008-04-242009-12-24Searete Llc, A Limited Liability Corporation Of The State Of DelawarMethods and systems for presenting a combination treatment
US20100004762A1 (en)*2008-04-242010-01-07Searete Llc, A Limited Liability Corporation Of The State Of DelawareComputational system and method for memory modification
US20100015583A1 (en)*2008-04-242010-01-21Searete Llc, A Limited Liability Corporation Of The State Of DelawareComputational System and method for memory modification
US20100017001A1 (en)*2008-04-242010-01-21Searete Llc, A Limited Liability Corporation Of The State Of DelawareComputational system and method for memory modification
US20100022820A1 (en)*2008-04-242010-01-28Searete Llc, A Limited Liability Corporation Of The State Of DelawareComputational system and method for memory modification
US20100030089A1 (en)*2008-04-242010-02-04Searete Llc, A Limited Liability Corporation Of The State Of DelawareMethods and systems for monitoring and modifying a combination treatment
US20100042578A1 (en)*2008-04-242010-02-18Searete Llc, A Limited Liability Corporation Of The State Of DelawareComputational system and method for memory modification
US20100041964A1 (en)*2008-04-242010-02-18Searete Llc, A Limited Liability Corporation Of The State Of DelawareMethods and systems for monitoring and modifying a combination treatment
US20090271121A1 (en)*2008-04-242009-10-29Searete Llc, A Limited Liability Corporation Of The State Of DelawareMethods and systems for detecting a bioactive agent effect
US20090271008A1 (en)*2008-04-242009-10-29Searete Llc, A Limited Liability Corporation Of The State Of DelawareCombination treatment modification methods and systems
US20100081861A1 (en)*2008-04-242010-04-01Searete LlcComputational System and Method for Memory Modification
US20100081860A1 (en)*2008-04-242010-04-01Searete Llc, A Limited Liability Corporation Of The State Of DelawareComputational System and Method for Memory Modification
US20100125561A1 (en)*2008-04-242010-05-20Searete Llc, A Limited Liability Corporation Of The State Of DelawareComputational system and method for memory modification
US7801686B2 (en)2008-04-242010-09-21The Invention Science Fund I, LlcCombination treatment alteration methods and systems
US7974787B2 (en)2008-04-242011-07-05The Invention Science Fund I, LlcCombination treatment alteration methods and systems
US8606592B2 (en)2008-04-242013-12-10The Invention Science Fund I, LlcMethods and systems for monitoring bioactive agent use
US8615407B2 (en)2008-04-242013-12-24The Invention Science Fund I, LlcMethods and systems for detecting a bioactive agent effect
US8682687B2 (en)2008-04-242014-03-25The Invention Science Fund I, LlcMethods and systems for presenting a combination treatment
US8876688B2 (en)2008-04-242014-11-04The Invention Science Fund I, LlcCombination treatment modification methods and systems
US10786626B2 (en)2008-04-242020-09-29The Invention Science Fund I, LlcMethods and systems for modifying bioactive agent use
US8930208B2 (en)2008-04-242015-01-06The Invention Science Fund I, LlcMethods and systems for detecting a bioactive agent effect
US9026369B2 (en)2008-04-242015-05-05The Invention Science Fund I, LlcMethods and systems for presenting a combination treatment
US9064036B2 (en)2008-04-242015-06-23The Invention Science Fund I, LlcMethods and systems for monitoring bioactive agent use
US9239906B2 (en)2008-04-242016-01-19The Invention Science Fund I, LlcCombination treatment selection methods and systems
US9282927B2 (en)2008-04-242016-03-15Invention Science Fund I, LlcMethods and systems for modifying bioactive agent use
US9358361B2 (en)2008-04-242016-06-07The Invention Science Fund I, LlcMethods and systems for presenting a combination treatment
US20100076249A1 (en)*2008-04-242010-03-25Searete Llc, A Limited Liability Corporation Of The State Of DelawareComputational system and method for memory modification
US9504788B2 (en)2008-04-242016-11-29Searete LlcMethods and systems for modifying bioactive agent use
US9560967B2 (en)2008-04-242017-02-07The Invention Science Fund I LlcSystems and apparatus for measuring a bioactive agent effect
US9649469B2 (en)2008-04-242017-05-16The Invention Science Fund I LlcMethods and systems for presenting a combination treatment
US9662391B2 (en)2008-04-242017-05-30The Invention Science Fund I LlcSide effect ameliorating combination therapeutic products and systems
US10572629B2 (en)2008-04-242020-02-25The Invention Science Fund I, LlcCombination treatment selection methods and systems
CN104138250A (en)*2008-12-292014-11-12美敦力迷你迈德公司System and/or method for glucose sensor calibration
CN114943249A (en)*2022-05-132022-08-26福州九候生医科技有限公司 Blood component detection method and related equipment

Also Published As

Publication numberPublication date
CA2481627C (en)2009-12-29
EP1518495B1 (en)2010-03-31
CA2481627A1 (en)2005-03-23
EP1518495A1 (en)2005-03-30
US7389133B1 (en)2008-06-17
ATE462350T1 (en)2010-04-15
JP4040614B2 (en)2008-01-30
ES2340383T3 (en)2010-06-02
US20060052679A1 (en)2006-03-09
US20050272985A1 (en)2005-12-08
DE502004010963D1 (en)2010-05-12
DE10343863A1 (en)2005-04-14
JP2005131370A (en)2005-05-26

Similar Documents

PublicationPublication DateTitle
US7389133B1 (en)Method and device for continuous monitoring of the concentration of an analyte
US20220354394A1 (en)Calibration of optical glucose sensors based on electrochemical glucose sensors
US7650244B2 (en)Method and device for monitoring analyte concentration by determining its progression in the living body of a human or animal
US11096611B2 (en)Method for providing a signal quality degree associated with an analyte value measured in a continuous monitoring system
EP0923335B1 (en)Implantable sensor and system for in vivo measurement and control of fluid constituent levels
US7384397B2 (en)System and method for sensor recalibration
EP1628569B1 (en)Tissue overgrowth compensated optical sensor
KR100499139B1 (en)Method of removing abnormal data and blood constituent analysing system using spectroscopy employing the same
US7672702B2 (en)Noninvasive in vivo measuring system and noninvasive in vivo measuring method by correcting influence of Hemoglobin
EP0404562A2 (en)Method of and apparatus for determining the similarity of a biological analyte from a model constructed from known biological fluids
US20140081152A1 (en)System and method for determining stability of cardiac output
EP2640266B1 (en)Coefficent determination for total hemoglobin concentration indices
US8734347B2 (en)Analytical method and investigation system
HK1021126B (en)Implantable sensor and system for in vivo measurement and control of fluid constituent levels

Legal Events

DateCodeTitleDescription
ASAssignment

Owner name:ROCHE DIAGNOSTICS GMBH, GERMANY

Free format text:ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KOTULLA, REINHARD;STAIB, ARNULF;GILLEN, RALPH;REEL/FRAME:020029/0172;SIGNING DATES FROM 20051018 TO 20051020

Owner name:ROCHE DIAGNOSTICS OPERATIONS, INC., INDIANA

Free format text:ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ROCHE DIAGNOSTICS GMBH;REEL/FRAME:020029/0278

Effective date:20051021

STCFInformation on status: patent grant

Free format text:PATENTED CASE

CCCertificate of correction
FPAYFee payment

Year of fee payment:4

ASAssignment

Owner name:ROCHE DIABETES CARE, INC., INDIANA

Free format text:ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ROCHE DIAGNOSTICS OPERATIONS, INC.;REEL/FRAME:036008/0670

Effective date:20150302

FPAYFee payment

Year of fee payment:8

MAFPMaintenance fee payment

Free format text:PAYMENT OF MAINTENANCE FEE, 12TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1553); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

Year of fee payment:12


[8]ページ先頭

©2009-2025 Movatter.jp